# The Second Affiliated Hospital of Chongqing Medical University

Organization · id `cardio:org-the-second-affiliated-hospital-of-chongqing-medical-739711` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=The+Second+Affiliated+Hospital+of+Chongqing+Medical+University>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: The Second Affiliated Hospital of Chongqing Medical University
- Sponsor class: OTHER

## Connected pages

- Sponsors: LAMax Vs. Watchman LAAC Device for Subjects With Non-valvular AF to Reduce the Risk of Stroke (`cardio:ct-nct04429646`)
- Sponsors: CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II (`cardio:ct-nct04516993`)
- Sponsors: The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble (`cardio:ct-nct06116357`)
- Sponsors: Tirofiban for Successful Endovascular Stroke Thrombectomy (`cardio:ct-nct06373042`)
- Sponsors: Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy (`cardio:ct-nct06501651`)
- Sponsors: Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction (`cardio:ct-nct06812546`)
- Sponsors: Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation (`cardio:ct-nct07926854`)

## Provenance

Content hash: cf45761b88584a8b4704b0eb7f2ef99a071ebf6b351606f144aa33a561d51763
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
